AAV MUTANT HAVING BRAIN-TARGETING PROPERTY Application EP-3960755-A4 European Patent Office 22 Nov 2023
Directed modified recombinant viral vectors and their use for targeted introduction of… Grant JP-7372154-B2 Japan 31 Oct 2023
Gene editing-based method of attenuating the beta-amyloid pathway Grant US-11701436-B2 United States of America 18 Jul 2023
NOVEL COMPOSITIONS WITH BRAIN-SPECIFIC TARGETING MOTIFS AND COMPOSITIONS CONTAINING SAME Application WO-2022226263-A1 World Intellectual Property Organisation (WIPO) 27 Oct 2022